Social media (SM) is now a popular place for content creation and a means of communication between young adults. Their increasing participation in our lives means that they replace us face to face contacts (FTF), which can affect our mental health. The above changes in communication habits may correlate with the occurrence of depressive states and a sense of social isolation. The aim of the study is to analyze the relationship between the use of MS and the occurrence of depressive states in young adults on the basis of selected literature. The topic of emotional support and a sense of social isolation will also be discussed. PubMed and Google Scholar databases were used to select the appropriate literature, and only research was used. The cited studies on the use of MS and depression showed that people who spent the most time on social media showed an increased risk of experiencing a depressed mood. Another study analyzed the likelihood of depression depending on the method of emotional support. The comparison of emotional support in FTF (face to face) communication with the support obtained through MS showed that the possibility of depressive symptoms was lower for FTF communication and higher for the second method, respectively. The use of social media among young adults contributes to an increased risk of depression, perceived social isolation and reduced emotional support. Moreover, it has been proven that addiction to MS positively correlates with the presence of depressive symptoms.
29 September 2023 in Annals of Agricultural and Environmental Medicine
Introduction and objective: Various types of social media (SM) have recently played a huge role in shaping the world and one’s self-esteem. Previous research on this issue has shown that frequent use of MS leads to the creation of unrealistic body image ideals. Time spent on SM is sometimes...
16 September 2025 in International Journal of Innovative Technologies in Social Science
Introduction and aim of the study: Obesity is a global health issue increasing risks for various diseases and straining healthcare systems. Traditional treatments often prove ineffective, spurring interest in new therapies. GLP-1 receptor agonists have emerged as promising options for treating obesity, gaining attention for their benefits on physical performance and body composition. The aim of this study is to review current knowledge on the mechanisms of action, clinical efficacy, and safety of GLP-1 receptor agonists in obesity treatment, including their implications for public health and potential relevance in physically active populations. Review methods: A literature review was conducted using databases such as PubMed and Google Scholar. The search included keywords like: Obesity; Glucagon-Like Peptide 1; Public Health; Sports Performance; Energy Metabolism. Current state of knowledge: GLP-1 receptor agonists can reduce body weight by 10–21% while decreasing risks of metabolic complications, such as type 2 diabetes and cardiovascular issues. Besides their primary effects, they also regulate appetite, enhance fat oxidation, and improve energy efficiency, attracting interest from physically active individuals looking to optimize body composition. Their action mechanisms include delayed gastric emptying, increased satiety, and enhanced insulin sensitivity. Summary: The use of GLP-1 receptor agonists marks significant progress in obesity treatment with vital public health benefits. However, their off-label use among athletes raises ethical and safety concerns, especially regarding potential lean body mass loss affecting performance.
25 July 2025 in International Journal of Innovative Technologies in Social Science
For a considerable length of time, artificial sweeteners have been seen as safe dietary ingredients, promoting weight control and regulating blood sugar levels. However, a growing number of scientific studies are questioning their supposed biological neutrality. Current analyses suggest that some of these substances may affect the composition and function of the gut microbiota, which in turn may affect the immune system and play a role in the development of chronic inflammatory bowel diseases such as ulcerative colitis and Crohn's disease. There is growing evidence of a potential link between long-term intake of artificial sweeteners and the onset of insulin resistance and type 2 diabetes. In addition, it has been noted that frequent consumption of artificially sweetened beverages may be associated with an increased risk of stroke, cardiovascular disease and higher overall mortality, especially among overweight or obese postmenopausal women. These substances are commonly used in protein supplements, energy drinks and sports supplements, which may also affect important post-exercise recovery processes - including inflammation, insulin regulation, gut function and hydration status. These observations highlight the need for further interdisciplinary research into the long-term effects of artificial sweeteners on metabolic health and overall body function, especially in groups with high levels of consumption, such as people with metabolic syndrome and patients with type 2 diabetes.
29 April 2025 in Journal of Education, Health and Sport
Advances in the understanding of Alzheimer’s disease (AD) pathophysiology, along with the development of neuroimaging and biomarker analysis, have enabled the detection of neurodegenerative changes even before clinical symptoms appear. This article explores the evolution of AD diagnostic criteria, with a particular focus on the pivotal role of cerebrospinal fluid biomarkers (Aβ42, t-tau, p-tau) and brain imaging techniques (MRI, PET). The A/T/N classification system and the concept of compensatory brain mechanisms are also discussed, emphasizing their relevance in early disease detection. The modern diagnostic approach, introduced by the Dubois criteria and further developed by the NIA-AA framework, allows for the identification of AD in its preclinical phase. The presence of biomarker abnormalities in asymptomatic individuals suggests a long latent period and the activation of neuroplastic compensatory processes that may delay symptom onset. The integration of biomarkers has significantly improved diagnostic accuracy, enhanced clinical trial participant selection, and enabled more precise disease monitoring. Despite these advances, effective treatments to halt or reverse disease progression remain elusive, highlighting the urgent need for further research into compensatory mechanisms, individual variability, and early therapeutic strategies.
5 August 2025 in International Journal of Innovative Technologies in Social Science
Acute Disseminated Encephalomyelitis (ADEM) is an acute, immune-mediated demyelinating disorder of the central nervous system, primarily affecting children between 3 and 7 years of age. It typically occurs 1–3 weeks after a viral, bacterial, or post-vaccination infection. Clinically, it presents with multifocal neurological deficits and encephalopathy, which may include altered consciousness, seizures, or cognitive disturbances. MRI shows widespread demyelinating lesions, mainly in the subcortical white matter. Laboratory findings may include elevated CRP, ESR, leukocytosis, and CSF pleocytosis. Treatment involves high-dose intravenous corticosteroids, with intravenous immunoglobulin or plasma exchange used in severe or refractory cases. Though usually monophasic, up to 25% of patients may experience relapses. Some children may require ICU care and early rehabilitation to address cognitive, motor, or speech deficits, highlighting the importance of timely diagnosis and management.